Dutasteride and bicalutamide in patients with hormone-refractory prostate cancer: the Therapy Assessed by Rising PSA (TARP) study rationale and design.

The Canadian journal of urology

Volumn 16, Issue 5, 2009, Pages 4806-4812

  Sartor, Oliver ^a   Gomella, Leonard G ^b   Gagnier, Paul ^b   Melich, Karen ^b   Dann, Rebekkah ^b  

^a TULANE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANILIDE; ANTIANDROGEN; ANTINEOPLASTIC HORMONE AGONISTS AND ANTAGONISTS; AZASTEROID; BICALUTAMIDE; DUTASTERIDE; ENZYME INHIBITOR; NITRILE; PROSTATE SPECIFIC ANTIGEN; STEROID 5ALPHA REDUCTASE INHIBITOR; TOLUENESULFONIC ACID DERIVATIVE; TUMOR MARKER;

ADULT; AGED; ARTICLE; BLOOD; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE COURSE; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; DRUG COMBINATION; DRUG RESISTANCE; FOLLOW UP; HUMAN; MALE; MIDDLE AGED; MULTICENTER STUDY; ORAL DRUG ADMINISTRATION; PROSTATE TUMOR; RANDOMIZED CONTROLLED TRIAL; RETROSPECTIVE STUDY; TREATMENT OUTCOME;

5-ALPHA REDUCTASE INHIBITORS; ADMINISTRATION, ORAL; ADULT; AGED; AGED, 80 AND OVER; ANDROGEN ANTAGONISTS; ANILIDES; ANTINEOPLASTIC AGENTS, HORMONAL; AZASTEROIDS; DISEASE PROGRESSION; DOSE-RESPONSE RELATIONSHIP, DRUG; DOUBLE-BLIND METHOD; DRUG RESISTANCE, NEOPLASM; DRUG THERAPY, COMBINATION; ENZYME INHIBITORS; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; NITRILES; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; RETROSPECTIVE STUDIES; TOSYL COMPOUNDS; TREATMENT OUTCOME; TUMOR MARKERS, BIOLOGICAL;

EID: 78649324127     PISSN: 11959479     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (0)